Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis

Decorative image of the AMR Learning Lounge

Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis

SUMMARY

In 2019, a select group of academic, federal, professional, industry, and patient representative organizations met to discuss best practices for improving patient safety through diagnostic stewardship. CDC members created this white paper as a way to push action items forward from this discussion and distribute the knowledge to a wider audience. The attendees affirmed the necessity that laboratory expertise be fully integrated in antibiotic stewardship programs and teams.

FEATURED EXPERTS

Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA

GET STARTED

The meetings covered the role of (EHR) in lab optimization, how testing can improve antimicrobial use in sepsis patients, and more.

Take me there now!

Estimated reading time: 15 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

US Solutions

VIDAS^® B•R•A•H•M•S PCT™

Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

Learn More